These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38738908)

  • 21. Sleep complaints are associated with reduced left prefrontal activation during a verbal fluency task in patients with major depression: A multi-channel near-infrared spectroscopy study.
    Nishida M; Kikuchi S; Matsumoto K; Yamauchi Y; Saito H; Suda S
    J Affect Disord; 2017 Jan; 207():102-109. PubMed ID: 27721182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe sleep disturbance is associated with executive function impairment in patients with first-episode, treatment-naïve major depressive disorders.
    Cui F; Liu Q; Lv X; Leonhart R; Tian H; Wei J; Zhang K; Zhu G; Chen Q; Wang G; Wang X; Zhang N; Huang Y; Si T; Yu X
    BMC Psychiatry; 2021 Apr; 21(1):198. PubMed ID: 33874911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep symptoms and long-term outcome in adolescents with major depressive disorder: a naturalistic follow-up study.
    Urrila AS; Kiviruusu O; Haravuori H; Karlsson L; Viertiö S; Suvisaari J; Marttunen M;
    Eur Child Adolesc Psychiatry; 2020 May; 29(5):595-603. PubMed ID: 31696307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depressive symptoms effect subjective sleep quality in Chinese patients with Parkinson's disease.
    Zhu J; Zhong M; Yan J; Wu Z; Pan Y; Shen B; Dong J; Zhang L
    Clin Neurol Neurosurg; 2020 Aug; 195():105950. PubMed ID: 32497937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familiality and clinical outcomes of sleep disturbances in major depressive and bipolar disorders.
    Lai YC; Huang MC; Chen HC; Lu MK; Chiu YH; Shen WW; Lu RB; Kuo PH
    J Psychosom Res; 2014 Jan; 76(1):61-7. PubMed ID: 24360143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in the mediators of functional disability in Major Depressive Disorder.
    Carmona NE; Subramaniapillai M; Mansur RB; Cha DS; Lee Y; Fus D; McIntyre RS
    J Psychiatr Res; 2018 Jan; 96():108-114. PubMed ID: 28992527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronotype and depressive symptoms in students: An investigation of possible mechanisms.
    Van den Berg JF; Kivelä L; Antypa N
    Chronobiol Int; 2018 Sep; 35(9):1248-1261. PubMed ID: 29764217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Sleep Disturbance Symptoms on Treatment Outcome in Blended Cognitive Behavioral Therapy for Depression (E-COMPARED Study): Secondary Analysis.
    Jensen ES; Ladegaard N; Mellentin AI; Ebert DD; Titzler I; Araya R; Cerga Pashoja A; Hazo JB; Holtzmann J; Cieslak R; Smoktunowicz E; Baños R; Herrero R; García-Palacios A; Botella C; Berger T; Krieger T; Holmberg TT; Topooco N; Andersson G; van Straten A; Kemmeren L; Kleiboer A; Riper H; Mathiasen K
    J Med Internet Res; 2022 Mar; 24(3):e30231. PubMed ID: 35311687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross-sectional analysis of baseline data from PERFORM-J.
    Sumiyoshi T; Watanabe K; Noto S; Sakamoto S; Moriguchi Y; Tan KHX; Hammer-Helmich L; Fernandez J
    J Affect Disord; 2019 Nov; 258():172-178. PubMed ID: 31426015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of sleep complaints and depression outcomes among participants in the standard medical intervention and long-term exercise study of exercise and pharmacotherapy for depression.
    Combs K; Smith PJ; Sherwood A; Hoffman B; Carney RM; Freedland K; Craighead WE; Blumenthal JA
    J Nerv Ment Dis; 2014 Feb; 202(2):167-71. PubMed ID: 24469530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive functioning throughout the treatment history of clinical late-life depression.
    Dzierzewski JM; Potter GG; Jones RN; Rostant OS; Ayotte B; Yang FM; Sachs BC; Feldman BJ; Steffens DC
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1076-84. PubMed ID: 25703072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial.
    Lazowski LK; Townsend B; Hawken ER; Jokic R; du Toit R; Milev R
    BMC Psychiatry; 2014 Jul; 14():202. PubMed ID: 25030264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar profiles of cognitive domain deficits between medication-naïve patients with bipolar II depression and those with major depressive disorder.
    Liu T; Zhong S; Wang B; Liao X; Lai S; Jia Y
    J Affect Disord; 2019 Jan; 243():55-61. PubMed ID: 30227315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
    Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ
    J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PSYCHOMETRIC properties of the Chinese version of the THINC-it tool for cognitive symptoms in patients with major depressive disorder.
    Hou Y; Yao S; Hu S; Zhou Q; Han H; Yu X; McIntyre RS; Shi C
    J Affect Disord; 2020 Aug; 273():586-591. PubMed ID: 32560957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.
    Quera-Salva MA; Lemoine P; Guilleminault C
    Hum Psychopharmacol; 2010 Apr; 25(3):222-9. PubMed ID: 20373473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.
    Cao B; Park C; Rosenblat JD; Chen Y; Iacobucci M; Subramaniapillai M; Mansur RB; Zuckerman H; Lee Y; McIntyre RS
    J Psychopharmacol; 2019 Nov; 33(11):1388-1394. PubMed ID: 31530216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep and body mass index in depressed children and healthy controls.
    Wojnar J; Brower KJ; Dopp R; Wojnar M; Emslie G; Rintelmann J; Hoffmann RF; Armitage R
    Sleep Med; 2010 Mar; 11(3):295-301. PubMed ID: 20138579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep disturbances in patients with major depressive disorder: incongruence between sleep log and actigraphy.
    Kung PY; Chou KR; Lin KC; Hsu HW; Chung MH
    Arch Psychiatr Nurs; 2015 Feb; 29(1):39-42. PubMed ID: 25634873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.